Free Trial

Equillium (EQ) SEC Filings & 10K Form

Equillium logo
$0.61 +0.01 (+1.33%)
(As of 12/20/2024 05:16 PM ET)

Recent Equillium SEC Filings

DateFilerForm TypeView
12/12/2024
4:43 PM
Colabuono Peter (Reporting)
Equillium (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/12/2024
4:45 PM
Colabuono Peter (Reporting)
Equillium (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
3:10 PM
Equillium (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
5:23 PM
Equillium (Issuer)
Keyes Jason A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
8:50 PM
Decheng Capital Management IV , LLC (0001843384) (Filed by)
Equillium (Subject)
Form SC 13G/A
10/31/2024
11:19 AM
Equillium (Subject)
Zedelmayer Christine (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/31/2024
6:05 AM
Equillium (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
7:59 PM
Equillium (Issuer)
Zedelmayer Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2024
3:15 PM
Equillium (Issuer)
Tom Penny (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2024
6:38 PM
Equillium (Issuer)
Keyes Jason A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
5:14 PM
Equillium (Issuer)
Tom Penny (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
3:01 PM
Equillium (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2024
4:52 PM
Equillium (Issuer)
Keyes Jason A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
1:08 PM
Equillium (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2024
3:26 PM
Equillium (Subject)
Keyes Jason A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/04/2024
7:00 AM
Equillium (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2024
4:54 PM
Equillium (Issuer)
Troupin Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
4:56 PM
Equillium (Issuer)
Xu Yu (0001843348) (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
4:59 PM
Equillium (Issuer)
McDermott Charles Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
5:00 PM
Equillium (Issuer)
MANIAN BALA S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
5:02 PM
Equillium (Issuer)
Pruzanski Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
5:04 PM
DEMSKI MARTHA J (Reporting)
Equillium (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
4:00 PM
Equillium (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2024
3:06 PM
Equillium (Filer)
Form DEF 14A
04/11/2024
3:07 PM
Equillium (Filer)
Form DEFA14A
04/11/2024
3:09 PM
Equillium (Filer)
Form ARS
04/01/2024
7:05 AM
Equillium (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2024
3:26 PM
Equillium (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/25/2024
3:05 PM
Equillium (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2024
3:11 PM
Equillium (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/08/2024
4:35 PM
Equillium (Issuer)
Tom Penny (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/23/2024
4:12 PM
Equillium (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/22/2024
5:08 AM
Equillium (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/19/2024
5:03 AM
Equillium (Subject)
TAKEDA PHARMACEUTICAL CO LTD (Filed by)
Form SC 13G
01/03/2024
5:10 PM
Equillium (Issuer)
Keyes Jason A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
5:12 PM
Equillium (Issuer)
Zedelmayer Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
5:14 PM
Equillium (Issuer)
Rothman Joel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
5:17 PM
Connelly Stephen (Reporting)
Equillium (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
5:19 PM
Equillium (Issuer)
Steel Bruce D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
5:20 PM
BRADBURY DANIEL (Reporting)
Equillium (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2023
7:05 AM
Equillium (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
We recommended Palantir in 2021, now we’re recommending this... (Ad)

My research indicates there is only one investment that can meet AI's unprecedented demand for energy.

Click to get the name and ticker symbol
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:EQ) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners